Evaluation of proctitis

Last reviewed: 21 Oct 2024
Last updated: 07 Nov 2024

Summary

Differentials

Common

  • Idiopathic ulcerative proctitis
  • Crohn proctitis
  • Sexually transmitted proctitis
Full details

Uncommon

  • Celiac disease
  • Radiation proctitis
  • Ischemic proctitis
  • Proctitis related to nonsteroidal anti-inflammatory drug use, caustic agent
  • Diversion colitis
  • Mpox
Full details

Contributors

Authors

Jordan E. Axelrad, MD, MPH

Associate Professor of Medicine

Director of Clinical and Translational Research

Inflammatory Bowel Disease Center at NYU Langone Health

NYU Grossman School of Medicine

New York

NY

Disclosures

JEA declares research grants from BioFire Diagnostics; consultancy fees, honorarium, or advisory board fees from Biomerieux, Janssen, Pfizer, BMS, Adiso, Fresenius, and Abbvie. JEA is supported through the Clinical Investigator Research Award funded by the Crohn’s and Colitis Foundation (#878246), the Judith & Stewart Colton Center for Autoimmunity, and the NIH NIDDK Diseases K23DK124570.

Acknowledgements

Dr Jordan E. Axelrad would like to gratefully acknowledge Dr Alan C. Moss, a previous contributor to this topic.

Disclosures

ACM declares that he has no competing interests.

Peer reviewers

Srikrishna Nagri, MD

Gastroenterologist

Dartmouth-Hitchcock Nashua

Nashua

NH

Disclosures

SN declares that he has no competing interests.

Terry Bolin, MBBS

Associate Professor of Medicine

Gastrointestinal and Liver Unit

The Prince of Wales Hospital

Sydney

New South Wales

Australia

Disclosures

TB declares that he has no competing interests.

Use of this content is subject to our disclaimer